SRx Health Solutions Files 8-K with Material Agreement

Ticker: SRXH · Form: 8-K · Filed: Dec 16, 2025 · CIK: 1471727

Sentiment: neutral

Topics: material-agreement, 8-k, corporate-filing

TL;DR

SRx Health Solutions just filed an 8-K for a material definitive agreement. Big news pending.

AI Summary

On December 16, 2025, SRx Health Solutions, Inc. filed an 8-K report detailing a material definitive agreement. The filing also included Regulation FD disclosures and financial statements/exhibits. The company, formerly known as Better Choice Co Inc. and Sport Endurance, Inc., is incorporated in Delaware and headquartered in North Palm Beach, Florida.

Why It Matters

This 8-K filing indicates a significant new agreement for SRx Health Solutions, Inc., which could impact its business operations and financial performance.

Risk Assessment

Risk Level: medium — Material definitive agreements can introduce new risks or opportunities that are not yet fully understood by the market.

Key Players & Entities

FAQ

What is the nature of the material definitive agreement filed by SRx Health Solutions, Inc.?

The filing indicates the entry into a material definitive agreement, but the specific details of the agreement are not provided in the provided text.

When was the earliest event reported in this 8-K filing?

The earliest event reported was on December 16, 2025.

What were SRx Health Solutions, Inc.'s former company names?

SRx Health Solutions, Inc. was formerly known as Better Choice Co Inc. and Sport Endurance, Inc.

In which state is SRx Health Solutions, Inc. incorporated?

SRx Health Solutions, Inc. is incorporated in Delaware.

Where are the principal executive offices of SRx Health Solutions, Inc. located?

The principal executive offices of SRx Health Solutions, Inc. are located in North Palm Beach, Florida.

Filing Stats: 2,111 words · 8 min read · ~7 pages · Grade level 15.4 · Accepted 2025-12-16 08:47:59

Key Financial Figures

Filing Documents

From the Filing

UNITED SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): December 16, 2025 SRx Health Solutions, Inc. (Exact name of Registrant as Specified in its Charter) Delaware 001-40477 83-4284557 (State or other Jurisdiction of Incorporation) (Commission File Number) (IRS Employer Identification No.) 801 US Highway 1 North Palm Beach , Florida 33408 (Address of Principal Executive Offices) (Zip Code) (Registrant's Telephone Number, Including Area Code): ( 212 ) 896-1254 N/A (Former name or former address, if changed since last report.) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock, $0.001 par value share SRXH NYSE American Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (240.12b-2 of this chapter). Emerging growth company If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. Item 1.01. Entry into a Material Definitive Agreement. On December 16, 2025, SRx Health Solutions, Inc. (the "Company") entered into a Share Exchange and Asset Transfer Agreement (the "Transfer Agreement"), as unanimously approved by the Board, by and among the Company, EMJ Crypto Technologies Inc., a corporation organized under the laws of Ontario, Canada ("EMJC"), CCC Crypto Corp., a Delaware corporation ("DelawareCo"), and the transferors named therein (the "Transferors"). Upon the terms and subject to the conditions set forth in the Transfer Agreement, the Company shall acquire EMJC and DelawareCo and acquire from certain Transferors all of their rights in and to the IP Asset (defined below), in an all-stock transaction, for an aggregate purchase price of approximately $55 million (the "Transaction"). The "IP Asset" means all intellectual property rights, whether or not registerable, in any jurisdiction in the world, including without limitation copyrights, patent rights, trademark rights, trade secrets, and software, in connection with certain technology developed by or on behalf of EMJC, DelawareCo and the Transferors that uses artificial intelligence to predict outcomes from data sets (including an algorithm which is designed to outperform Bitcoin and Ethereum based on trading volatility), including all know-how, trade secrets, coding (source code and object code), designs, data, algorithms, formulae, specifications, processes, procedures, methods, techniques, ideas, software, tools, inventions, apparatus, creations, works of authorship (whether or not copyrighted) and other similar materials, and all reports, analyses, results and records relating to any of the foregoing, in each case in any form or embodied in any media, and whether or not registrable. The completion of the Transaction is subject to customary closing conditions, including (i) approval of the Transaction by the Company's stockholders, (ii) filing and mailing of a definitive information statement filed with the Securities and Exchange Commission (the "SEC"), (iii) the shares of the Company's comm stock to be issued pursuant to the Transfer Agreement having been approved for listing on the NYSE American, (iv) the Company shall file with the SEC a registration statement on Form S-4 (the "Registration Statement"), in connection with the registration under the Securities Act of 1933, as amended ("Securities Act") of the Company's common shares to be issued in the Transaction for resale by such holders, (v) subject to specified materiality standards, the accuracy of the representations and warranties of the other parties; and (vi) the performance by the other parties in all material respects with all obligations required to be performed under the Transfer Agreement at or prior to the date (the "Closing Date") of the closing of the transactions contemplated by the Transfer Agreement (the "Closing"). The Transfer Agreement may be terminated under cer

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing